CytoTronics, Inc.
Boston, MA, USA
At CytoTronics, we are transforming cell biology discovery with our high-throughput, semiconductor-based platforms. Our Pixel systems provide live cell insights with single-cell resolution across all cell types. By seamlessly integrating semiconductors with conventional microplates, Pixel unlocks multi-modal electrical, electrochemical, and electrophysiological capabilities, delivering an unprecedented scope of data collection and scale-up for cell biology research, drug development, and pharmaceutical manufacturing applications. Established as a spin-off from Harvard University in 2021, we are headquartered in Boston, Massachusetts. Learn more at www.cytotronics.com or follow us on LinkedIn. The company raise $9.25M in Series Seed 1 in Q4 2021 then closed $13.5M in the Series Seed 2 in Q3 2024. The company will initiate conversations on the Series-A financing with select and target investors at the JPMorgan Healthcare conference in January 2025. The VP, Finance should have past...